Splicing factor RBM10 loss fuels thyroid cancer metastasis
Related Experiment Video
Updated: May 26, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Kevin Coughlin1, Ledong Wan1,2
1Department of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY, USA.
Abstract:
In this issue of JEM, Krishnamoorthy et al. (https://doi.org/10.1084/jem.20241029) identify the loss of the splicing factor RBM10 as a driver of metastasis in thyroid cancer through the regulation of RNA splicing. The synthetic lethal interaction between NF-κB and RBM10 loss reveals a potential therapeutic vulnerability.
Insights
Loss of the splicing factor RBM10 drives thyroid cancer metastasis by altering RNA splicing. This discovery reveals a potential therapeutic vulnerability linked to NF-κB signaling.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Thyroid cancer metastasis remains a significant clinical challenge.
- The role of RNA splicing regulation in cancer progression is increasingly recognized.
Purpose of the Study:
- To investigate the role of the splicing factor RBM10 in thyroid cancer metastasis.
- To identify potential therapeutic targets based on molecular alterations in thyroid cancer.
Main Methods:
- Analysis of RNA splicing patterns in thyroid cancer.
- Investigating the functional impact of RBM10 loss in cancer cells.
- Exploring synthetic lethal interactions involving RBM10 and NF-κB pathways.
Main Results:
- Loss of RBM10 was identified as a key driver of thyroid cancer metastasis.
- RBM10 regulates metastasis through the modulation of RNA splicing.
- A synthetic lethal interaction between NF-κB and RBM10 loss was uncovered.
Conclusions:
- RBM10 is a critical regulator of RNA splicing and a driver of thyroid cancer metastasis.
- Targeting the interplay between NF-κB and RBM10 loss presents a promising therapeutic strategy for thyroid cancer.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

